|
SERAC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.057960E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.462200E-01 |
| Normal-vs-Stage2 |
4.162200E-02 |
| Normal-vs-Stage3 |
5.851600E-02 |
| Normal-vs-Stage4 |
4.299300E-03 |
| Stage1-vs-Stage2 |
1.024390E-01 |
| Stage1-vs-Stage3 |
1.272160E-01 |
| Stage1-vs-Stage4 |
1.783570E-02 |
| Stage2-vs-Stage3 |
6.677000E-01 |
| Stage2-vs-Stage4 |
6.259400E-01 |
| Stage3-vs-Stage4 |
3.029200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.087360E-01 |
| Normal-vs-AfricanAmerican |
5.857400E-01 |
| Normal-vs-Asian |
1.454560E-01 |
| Caucasian-vs-AfricanAmerican |
7.760000E-01 |
| Caucasian-vs-Asian |
8.578000E-01 |
| AfricanAmerican-vs-Asian |
7.243800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.247670E-02 |
| Normal-vs-Female |
2.281200E-01 |
| Male-vs-Female |
5.446100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.195000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.601800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.218000E-02 |
| Normal-vs-Age(81-100Yrs) |
2.421500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.322000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.997800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.064550E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.003600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.220200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.536200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.157200E-01 |
| Classical-VS-Follicular |
2.119900E-02 |
| Classical-VS-Other |
1.627810E-01 |
| Classical-VS-Normal |
3.836200E-01 |
| Tall-VS-Follicular |
4.498600E-01 |
| Tall-VS-Other |
3.103800E-01 |
| Tall-VS-Normal |
2.169800E-01 |
| Follicular-VS-Other |
5.655600E-01 |
| Follicular-VS-Normal |
1.891670E-02 |
| Other-VS-Normal |
6.670000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.418300E-02 |
| Normal-vs-N1 |
5.656000E-02 |
| N0-vs-N1 |
4.849200E-01 |
|
|
